VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells.
about
CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.Targeted exon sequencing fails to identify rare coding variants with large effect in rheumatoid arthritisVSTM-v1, a potential myeloid differentiation antigen that is downregulated in bone marrow cells from myeloid leukemia patients.Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.The Secreted Form of Transmembrane Protein 98 Promotes the Differentiation of T Helper 1 Cells.FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages.Efficient production of CYTL1 protein using mouse IgGκ signal peptide in the CHO cell expression systemSynergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells.Cytokine-like 1 Chemoattracts Monocytes/Macrophages via CCR2.Preparation and characterization of monoclonal antibodies against VSTM1.LYG1 exerts antitumor function through promoting the activation, proliferation, and function of CD4+ T cells.
P2860
Q24306296-EA0C8C56-2246-4E7F-9D6F-C45CD7D0881FQ34375217-97F8145B-B503-4146-9CCA-67EB6B42D589Q35519772-CF0F2AD6-5B57-4BE8-820C-DC2624295ABFQ35892485-394F165D-6E05-48A1-BC03-20498215E0CDQ36030309-4C7C39E5-F4DB-414C-8D6E-95D736B95893Q36085062-A1407D32-748E-48DE-99D3-7A6DD80059B0Q36949603-C0F078AA-AD7F-45D2-BA10-766D66893C3EQ38754849-6486BC98-BE6D-4C4A-8D72-61A71ACBB7A7Q39847007-033E4DB3-73C6-43C1-9886-F46BE388C1DDQ42537189-D778B4A7-4AF4-4503-B611-08D647BD99C3Q50642148-4EE5345A-DDEE-4901-A7AB-9A9CC0F1FCA7
P2860
VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@ast
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@en
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@nl
type
label
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@ast
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@en
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@nl
prefLabel
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@ast
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@en
VSTM1-v2, a novel soluble glyc ...... and activation of Th17 cells.
@nl
P2093
P1433
P1476
VSTM1-v2, a novel soluble glyc ...... n and activation of Th17 cells
@en
P2093
Pingzhang Wang
Taiping Shi
Wenling Han
Xiaoning Mo
Yanfei Zhang
Yingyu Chen
Zhixin Zhang
P304
P356
10.1016/J.CELLIMM.2012.07.009
P50
P577
2012-07-01T00:00:00Z